Bgm (BGM) Shares Outstanding (Diluted) (2019 - 2026)
Analysis
Bgm (BGM) Shares Outstanding (Diluted) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.61 Bn | 38.95 Bn | 2.15 Bn | 1.17 Bn |
| 2 | Viatris | 19.14 Bn | 18.25 Bn | 1.46 Bn | 1.16 Bn |
| 3 | Dr Reddys Laboratories | 9.85 Bn | 9.68 Bn | 396.53 Mn | 833.33 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 328.10 Mn |
| 5 | Bausch Health Companies | 2.38 Bn | 541.37 Mn | 2.10 Bn | 378.10 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 291.34 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 21.92 Mn |
| 8 | Amphastar Pharmaceuticals | 992.25 Mn | 702.12 Mn | 93.47 Mn | 44.23 Mn |
| 9 | Fennec Pharmaceuticals | 410.57 Mn | 369.32 Mn | 17.15 Mn | 36.43 Mn |
| 10 | Bgm | 31.79 Mn | 20.27 Mn | - | 113.26 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 113.26 Mn |
| Sep 30, 2025 | 113.26 Mn |
| Mar 31, 2025 | 7.23 Mn |
| Sep 30, 2024 | 7.23 Mn |
| Mar 31, 2024 | 7.15 Mn |
| Sep 30, 2023 | 7.15 Mn |
| Mar 31, 2023 | 7.15 Mn |
| Sep 30, 2022 | 7.15 Mn |
| Mar 31, 2022 | 6.82 Mn |
| Sep 30, 2021 | 6.82 Mn |
| Mar 31, 2021 | 6.00 Mn |
| Sep 30, 2020 | 6.00 Mn |
| Sep 30, 2019 | 6.00 Mn |